8-K



 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
April 27, 2016
Date of Report (Date of Earliest Event Reported)
 
The Chemours Company
(Exact Name of Registrant as Specified in Its Charter)
 

 
 
 
 
 
 
Delaware
 
001-36794
 
46-4845564
(State or Other Jurisdiction
 
(Commission
 
(I.R.S. Employer
Of Incorporation)
 
File Number)
 
Identification No.)
 
1007 Market Street
Wilmington, Delaware, 19899
(Address of principal executive offices)
 
Registrant’s telephone number, including area code: (302) 773-1000
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 
 
 





Item 5.07
Submission of Matters to a Vote of Security Holders.
The Chemours Company (the “Company”) held its first annual meeting of stockholders on April 27, 2016 (the “Annual Meeting”).
At the Annual Meeting, stockholders voted (i) in favor of the election of the directors listed below; (ii) in favor of the advisory vote on the compensation of the Company’s named executive officers; (iii) in favor of “one year” for the frequency of the Company’s advisory vote on the compensation of its named executive officers; (iv) in favor of the ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2016; and (v) against the retention of the classified structure for the Company’s board of directors.
The final voting results for each of these proposals are as follows:
Proposal 1 - Election of Directors
Nominee
For
Against
Abstain
Broker Non-Vote
Bradley J. Bell
116,066,146
2,038,464
319,627
38,579,547
Mary B. Cranston
116,026,424
2,106,765
291,051
38,579,544

Proposal 2 - Advisory Vote to Approve Named Executive Officer Compensation
For
Against
Abstain
Broker Non-Votes
111,816,197
5,929,240
678,792
38,579,555

Proposal 3 - Advisory Vote on Frequency of Advisory Vote to Approve Named Executive Officer Compensation
One Year*
Two Year
Three Year
Abstain
Broker Non-Vote
99,145,497
1,648,248
16,931,098
699,388
38,579,553

* The Company will include a stockholder vote on the compensation of executives in its proxy materials every year until the next required vote on the frequency of stockholder votes on the compensation of executives.

Proposal 4 - Ratification of Selection of Independent Registered Public Accounting Firm
For
Against
Abstain
155,466,676
1,026,601
510,507

Proposal 5 - Retention of the Classified Structure of the Board of Directors
For
Against
Abstain
Broker Non-Vote
4,052,498
113,525,867
845,864
38,579,555







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


THE CHEMOURS COMPANY
 
By:
 
/s/ Mark E. Newman
 
 
Mark E. Newman
 
 
Senior Vice President and
 
 
Chief Financial Officer
 
Date:
 
May 2, 2016